Sales Soar for Heidelberg Engineering at Ophthalmology Meeting.

VISTA, Calif. -- Heidelberg Engineering recorded 30% higher sales for its HRT product line at this year's American Academy of Ophthalmology meeting held last week (Oct. 23-26) in New Orleans.

"We believe the recently released data from the Ocular Hypertension Treatment Study (OHTS), comparing the Heidelberg Retina Tomograph (HRT) to expert interpretation of stereo fundus photographs, has convinced ophthalmologists and optometrists of the superiority of our advanced laser imaging technology," said Travis Lindsay, chief operating officer. "The HRT continues to be the only laser imaging device with longitudinal data and progression analysis for glaucoma."

The company also attracted attention with its confocal laser microscope for corneal imaging, a combination of the company's HRT and the Rostock Cornea Module. The microscope enables detailed cellular viewing of the cornea, important for refractive laser surgery, implantable contact lenses, cataract surgery and long-term contact lens wear. It is the first such device cleared by the Food and Drug Administration (FDA).

Headquartered near Heidelberg, Germany, the privately-held company is the leader in laser diagnostics for ophthalmic applications, and has the world's largest installed base of laser imaging equipment. The company designs, manufactures and markets a variety of instruments for application in retina, glaucoma and cornea diseases.